The Endocrine Society has released a position statement on transgender health. The statement notes the increase in societal awareness of transgender individuals, along with evidence-based and data-driven protocols. Thus, a framework for providing care is emerging, pointing to the need for policy changes. Among the positions outlined:
- There is a durable biological underpinning to gender identity that should be considered in policy determinations.
- Medical intervention for transgender individuals is effective, relatively safe, and has been established as the standard of care. Federal and private insurers should cover these interventions, as well as appropriate screenings.
- Increased funding for national research programs is needed to close the gaps in knowledge regarding transgender medical care and should be made a priority.
Transgender health: An Endocrine Society position statement. Endocrine Society web site. http://www.endocrine.org/advocacy/priorities-and-positions/transgender-h.... Updated September 13, 2017. Accessed October 4, 2017.
This Week's Must Reads
Cochrane on Clinician-Focused Weight Loss Tactics, Cochrane; 2017 Nov 30; Flodgren, et al
Cochrane on Delaying Diabetes in People with IGT, Cochrane; 2017 Dec 5; Hemmingsen, et al
Consider Using This Risk Tool to Predict T2D Risk, Diabetes Care; ePub 2017 Dec 1; Bergmark, Bhatt, et al
Dysglycemia Cause in Overweight Adults, Teens, Diabetes Care; ePub 2017 Nov 28; Chen, et al
FDA Approves Semaglutide for Type 2 Diabetes, Novo Nordisk news release; 2017 Dec 5
Must Reads in Clinical Guidelines
Cochrane on Diet/Exercise Role in Preventing GDM, Cochrane, 2017 Nov 12; Shepherd, Gomersal, et al
Cochrane on Insulin vs Oral Meds for GDM, Cochrane; 2017 Nov 5; Brown, Grzeskowiak, et al
Cochrane on Glucose Monitoring to Manage GDM, Cochrane, 2017 Oct 29; Raman, Shepherd, et al
New ADA Scientific Statement on CGM Systems, Diabetes Care; ePub 2017 Oct 25; Petrie, et al
Predicting Diabetes Based on HbA1c Levels, Diabetes Care; ePub 2017 Oct 26; Leong, et al